Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms

2008289 citationsJournal Article

Authors

Martín E. Stryjewski · Clinical Research Institute

Donald R. Graham · Springfield Clinic

Samuel E. Wilson · University of California, Irvine

William O’Riordan

David M. Young · University of California, San Francisco

Arnold Lentnek · WellStar Health System

Douglas P. Ross · St. Mary’s Hospital

Abstract

Telavancin given once daily is at least as effective as vancomycin for the treatment of patients with complicated skin and skin-structure infections, including those infected with methicillin-resistant S. aureus.

Topics & Keywords

Antimicrobial Resistance in Staphylococcus Bacterial Identification and Susceptibility Testing Antifungal resistance and susceptibility

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Infectious Diseases

Volume 46, Issue 11, pp. 1683-1693

DOI: 10.1086/587896

Field-Weighted Citation Impact: 18.48